| PROMIS pediatric measures in pediatric oncology: Valid and clinically feasible indicators of patient‐reported outcomes PS Hinds, SL Nuss, KS Ruccione, JS Withycombe, S Jacobs, H DeLuca, ... Pediatric blood & cancer 60 (3), 402-408, 2013 | 206 | 2013 |
| Weight patterns in children with higher risk ALL: a report from the Children's Oncology Group (COG) for CCG 1961 JS Withycombe, JE Post‐White, JL Meza, RG Hawks, LM Smith, N Sacks, ... Pediatric blood & cancer 53 (7), 1249-1254, 2009 | 141 | 2009 |
| Use of a fitness tracker to promote physical activity in children with acute lymphoblastic leukemia MC Hooke, L Gilchrist, L Tanner, N Hart, JS Withycombe Pediatric blood & cancer 63 (4), 684-689, 2016 | 124 | 2016 |
| Patient/family education for newly diagnosed pediatric oncology patients: Consensus recommendations from a Children’s Oncology Group Expert Panel W Landier, JA Ahern, LP Barakat, S Bhatia, KM Bingen, PG Bondurant, ... Journal of Pediatric Oncology Nursing 33 (6), 422-431, 2016 | 95 | 2016 |
| Outcome and prognostic factors in stage III favorable-histology Wilms tumor: A report from the children’s oncology group study AREN0532 CV Fernandez, EA Mullen, YY Chi, PF Ehrlich, EJ Perlman, ... Journal of Clinical Oncology 36 (3), 254, 2018 | 87 | 2018 |
| Processing information after a child’s cancer diagnosis—How parents learn: A report from the Children’s Oncology Group CC Rodgers, K Stegenga, JS Withycombe, K Sachse, KP Kelly Journal of Pediatric Oncology Nursing 33 (6), 447-459, 2016 | 86 | 2016 |
| Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the Children's Oncology Group JS Withycombe, LM Smith, JL Meza, C Merkle, MS Faulkner, L Ritter, ... Pediatric blood & cancer 62 (3), 434-439, 2015 | 83 | 2015 |
| Agreement between child self-report and caregiver-proxy report for symptoms and functioning of children undergoing cancer treatment JW Mack, M McFatrich, JS Withycombe, SH Maurer, SS Jacobs, L Lin, ... JAMA pediatrics 174 (11), e202861-e202861, 2020 | 82 | 2020 |
| Child and adolescent self-report symptom measurement in pediatric oncology research: a systematic literature review LC Pinheiro, M McFatrich, N Lucas, JS Walker, JS Withycombe, PS Hinds, ... Quality of Life Research 27 (2), 291-319, 2018 | 77 | 2018 |
| Endogenous factor VIII synthesis from the intron 22–inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A GS Pandey, C Yanover, LM Miller-Jenkins, S Garfield, SA Cole, JE Curran, ... Nature medicine 19 (10), 1318, 2013 | 63 | 2013 |
| Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events BB Reeve, M McFatrich, JW Mack, SH Maurer, SS Jacobs, DR Freyer, ... JNCI: Journal of the National Cancer Institute 112 (11), 1143-1152, 2020 | 56 | 2020 |
| Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events BB Reeve, M McFatrich, JW Mack, SH Maurer, SS Jacobs, DR Freyer, ... JNCI: Journal of the National Cancer Institute 112 (11), 1143-1152, 2020 | 56 | 2020 |
| Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient‐Reported Outcomes version of the Common … BB Reeve, M McFatrich, LC Pinheiro, MS Weaver, L Sung, ... Pediatric blood & cancer 64 (3), e26261, 2017 | 53 | 2017 |
| Factor VIII gene variants and inhibitor risk in African American hemophilia A patients D Gunasekera, RA Ettinger, S Nakaya Fletcher, EA James, M Liu, ... Blood, The Journal of the American Society of Hematology 126 (7), 895-904, 2015 | 52 | 2015 |
| The first step to integrating the child's voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology clinicians BB Reeve, JS Withycombe, JN Baker, MC Hooke, JC Lyons, C Mowbray, ... Pediatric blood & cancer 60 (7), 1231-1236, 2013 | 45 | 2013 |
| Expanding construct validity of established and new PROMIS Pediatric measures for children and adolescents receiving cancer treatment BB Reeve, M McFatrich, JW Mack, LC Pinheiro, SS Jacobs, JN Baker, ... Pediatric Blood & Cancer, e28160, 2020 | 43 | 2020 |
| Cognitive interview-based validation of the patient-reported outcomes version of the common terminology criteria for adverse events in adolescents with cancer BB Reeve, M McFatrich, LC Pinheiro, DR Freyer, EM Basch, JN Baker, ... Journal of pain and symptom management 53 (4), 759-766, 2017 | 38 | 2017 |
| Concept‐elicitation phase for the development of the pediatric patient‐reported outcome version of the Common Terminology Criteria for Adverse Events MS Weaver, BB Reeve, JN Baker, CE Martens, M McFatrich, C Mowbray, ... Cancer 122 (1), 141-148, 2016 | 34 | 2016 |
| Lack of concordance in symptomatic adverse event reporting by children, clinicians, and caregivers: implications for cancer clinical trials DR Freyer, L Lin, JW Mack, SH Maurer, M McFatrich, JN Baker, ... Journal of Clinical Oncology 40 (15), 1623-1634, 2022 | 32 | 2022 |
| A comprehensive survey of institutional patient/family educational practices for newly diagnosed pediatric oncology patients: A report from the Children’s Oncology Group JS Withycombe, R Andam-Mejia, A Dwyer, A Slaven, K Windt, W Landier Journal of Pediatric Oncology Nursing 33 (6), 414-421, 2016 | 32 | 2016 |
